MXPA03008849A - Inhibidores de la procolageno c proteinasa del tipo de acidos 3-heterociclilpropanohidroxamicos. - Google Patents
Inhibidores de la procolageno c proteinasa del tipo de acidos 3-heterociclilpropanohidroxamicos.Info
- Publication number
- MXPA03008849A MXPA03008849A MXPA03008849A MXPA03008849A MXPA03008849A MX PA03008849 A MXPA03008849 A MX PA03008849A MX PA03008849 A MXPA03008849 A MX PA03008849A MX PA03008849 A MXPA03008849 A MX PA03008849A MX PA03008849 A MXPA03008849 A MX PA03008849A
- Authority
- MX
- Mexico
- Prior art keywords
- heterocyclylpropanohydroxamic
- pcp inhibitors
- inhibitors
- acid pcp
- heterocyclylpropanohydroxamic acid
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
- C07D263/02—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
- C07D263/30—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D263/34—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P41/00—Drugs used in surgical methods, e.g. surgery adjuvants for preventing adhesion or for vitreum substitution
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D271/00—Heterocyclic compounds containing five-membered rings having two nitrogen atoms and one oxygen atom as the only ring hetero atoms
- C07D271/02—Heterocyclic compounds containing five-membered rings having two nitrogen atoms and one oxygen atom as the only ring hetero atoms not condensed with other rings
- C07D271/06—1,2,4-Oxadiazoles; Hydrogenated 1,2,4-oxadiazoles
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D271/00—Heterocyclic compounds containing five-membered rings having two nitrogen atoms and one oxygen atom as the only ring hetero atoms
- C07D271/02—Heterocyclic compounds containing five-membered rings having two nitrogen atoms and one oxygen atom as the only ring hetero atoms not condensed with other rings
- C07D271/06—1,2,4-Oxadiazoles; Hydrogenated 1,2,4-oxadiazoles
- C07D271/07—1,2,4-Oxadiazoles; Hydrogenated 1,2,4-oxadiazoles with oxygen, sulfur or nitrogen atoms, directly attached to ring carbon atoms, the nitrogen atoms not forming part of a nitro radical
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Engineering & Computer Science (AREA)
- Public Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Surgery (AREA)
- Ophthalmology & Optometry (AREA)
- Pulmonology (AREA)
- Gastroenterology & Hepatology (AREA)
- Dermatology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
- Plural Heterocyclic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Peptides Or Proteins (AREA)
- Pyridine Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB0108097.7A GB0108097D0 (en) | 2001-03-30 | 2001-03-30 | Compounds |
| PCT/IB2002/000817 WO2002079175A1 (en) | 2001-03-30 | 2002-03-18 | 3-heterocyclylpropanohydroxamic acid pcp inhibitors |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MXPA03008849A true MXPA03008849A (es) | 2003-12-11 |
Family
ID=9911979
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MXPA03008849A MXPA03008849A (es) | 2001-03-30 | 2002-03-18 | Inhibidores de la procolageno c proteinasa del tipo de acidos 3-heterociclilpropanohidroxamicos. |
Country Status (16)
| Country | Link |
|---|---|
| EP (1) | EP1373231B1 (es) |
| JP (1) | JP2004524364A (es) |
| AP (1) | AP2002002464A0 (es) |
| AT (1) | ATE297382T1 (es) |
| BR (1) | BR0208500A (es) |
| CA (1) | CA2442483C (es) |
| DE (1) | DE60204552T2 (es) |
| ES (1) | ES2240703T3 (es) |
| GB (1) | GB0108097D0 (es) |
| GT (1) | GT200200055A (es) |
| MX (1) | MXPA03008849A (es) |
| PA (1) | PA8542301A1 (es) |
| PE (1) | PE20021104A1 (es) |
| TN (1) | TNSN02035A1 (es) |
| UY (1) | UY27231A1 (es) |
| WO (1) | WO2002079175A1 (es) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2009097893A1 (en) * | 2008-02-04 | 2009-08-13 | Proyecto De Biomedicina Cima, S.L. | Methods for the treatment of cardiac disease associated to myocardial fibrosis using an inhibitor of pcp |
| CR20160316A (es) | 2014-01-10 | 2016-09-19 | Glaxosmithkline Intellectual Property (No 2) Ltd | Compuestos derivados de hidroxiformamida y usos del mismo |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| RU2232751C2 (ru) * | 1998-12-22 | 2004-07-20 | Ф.Хоффманн-Ля Рош Аг | Производные сульфонамидов и фармацевтическая композиция |
| HUP0201714A3 (en) * | 1999-03-03 | 2003-05-28 | Procter & Gamble | Substituted heterocyclic compounds and pharmaceutical compositions containing them |
| GB9930570D0 (en) * | 1999-12-23 | 2000-02-16 | Pfizer Ltd | Therapy |
-
2001
- 2001-03-30 GB GBGB0108097.7A patent/GB0108097D0/en not_active Ceased
-
2002
- 2002-03-18 AT AT02707045T patent/ATE297382T1/de not_active IP Right Cessation
- 2002-03-18 DE DE60204552T patent/DE60204552T2/de not_active Expired - Fee Related
- 2002-03-18 ES ES02707045T patent/ES2240703T3/es not_active Expired - Lifetime
- 2002-03-18 EP EP02707045A patent/EP1373231B1/en not_active Expired - Lifetime
- 2002-03-18 MX MXPA03008849A patent/MXPA03008849A/es active IP Right Grant
- 2002-03-18 JP JP2002577802A patent/JP2004524364A/ja not_active Ceased
- 2002-03-18 CA CA002442483A patent/CA2442483C/en not_active Expired - Fee Related
- 2002-03-18 BR BR0208500-3A patent/BR0208500A/pt not_active IP Right Cessation
- 2002-03-18 WO PCT/IB2002/000817 patent/WO2002079175A1/en active IP Right Grant
- 2002-03-21 GT GT200200055A patent/GT200200055A/es unknown
- 2002-03-27 PA PA20028542301A patent/PA8542301A1/es unknown
- 2002-03-27 UY UY27231A patent/UY27231A1/es not_active Application Discontinuation
- 2002-03-27 PE PE2002000250A patent/PE20021104A1/es not_active Application Discontinuation
- 2002-03-28 AP APAP/P/2002/002464A patent/AP2002002464A0/en unknown
- 2002-03-29 TN TNTNSN02035A patent/TNSN02035A1/fr unknown
Also Published As
| Publication number | Publication date |
|---|---|
| PA8542301A1 (es) | 2002-10-28 |
| EP1373231A1 (en) | 2004-01-02 |
| DE60204552D1 (en) | 2005-07-14 |
| AP2002002464A0 (en) | 2002-06-30 |
| DE60204552T2 (de) | 2006-05-11 |
| ATE297382T1 (de) | 2005-06-15 |
| UY27231A1 (es) | 2002-11-29 |
| JP2004524364A (ja) | 2004-08-12 |
| CA2442483C (en) | 2007-11-13 |
| GB0108097D0 (en) | 2001-05-23 |
| GT200200055A (es) | 2002-11-21 |
| EP1373231B1 (en) | 2005-06-08 |
| CA2442483A1 (en) | 2002-10-10 |
| PE20021104A1 (es) | 2002-12-07 |
| WO2002079175A1 (en) | 2002-10-10 |
| TNSN02035A1 (fr) | 2005-12-23 |
| BR0208500A (pt) | 2004-04-20 |
| ES2240703T3 (es) | 2005-10-16 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MXPA03008177A (es) | Inhibidores de metaloproteinasa.. | |
| MXPA03008180A (es) | Inhibidores de metaloproteinasa. | |
| MXPA03001832A (es) | Derivados de hidroxamato utiles como inhibidores de desacetilasa. | |
| MXPA03005838A (es) | Inhibidores de antigenos de aparicion muy tardia-4. | |
| MXPA03009647A (es) | Heterociclildicarbamidas como inhibidores de caspasa. | |
| ZA200410015B (en) | Pharmaceutical salts. | |
| MXPA03008183A (es) | Inhibidores de metaloproteinasa. | |
| ZA200208561B (en) | Hydraulischer druckverstarker. | |
| MXPA03007310A (es) | Derivados de ftalazinona piperidino como inhibidores pde4. | |
| ZA200309934B (en) | Connector for timber brandering. | |
| MXPA01009037A (es) | I-bet. | |
| MXPA03006467A (es) | Inibidores de naaladasa a base de tiol. | |
| MXPA03007869A (es) | Inhibidores peptidicos de desformilasa. | |
| MXPA03008139A (es) | Fluoralcoxifenilsulfonilureas sustituidas. | |
| MXPA03005302A (es) | Solucion acuosa para remover pintura. | |
| MX263097B (es) | Inhibidores de entrada a moleculas pequenas. | |
| PL364901A1 (en) | Oxalic acid derivatives | |
| ZA200408511B (en) | Plasma carboxypeptidase B inhibitors. | |
| HK1059781A1 (en) | New phenylpiperazines. | |
| MXPA03008849A (es) | Inhibidores de la procolageno c proteinasa del tipo de acidos 3-heterociclilpropanohidroxamicos. | |
| MXPA03004542A (es) | Inhibidores de proteasa. | |
| AU2002241204A1 (en) | 3-heterocyclylpropanohydroxamic acid pcp inhibitors | |
| HK1050120A1 (en) | Watchband. | |
| ZA200003398B (en) | Inhibitors. | |
| ZA200003399B (en) | Inhibitors. |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FG | Grant or registration |